Human Growth Hormone Market by Route of Administration (Intramuscular, Intravenous, Oral), Type (Amino Acid Derivatives, Peptide Hormones, Steroid Hormones), Distribution, Application - Global Forecast 2024-2030

Human Growth Hormone Market by Route of Administration (Intramuscular, Intravenous, Oral), Type (Amino Acid Derivatives, Peptide Hormones, Steroid Hormones), Distribution, Application - Global Forecast 2024-2030


The Human Growth Hormone Market size was estimated at USD 5.77 billion in 2023 and expected to reach USD 6.28 billion in 2024, at a CAGR 8.87% to reach USD 10.46 billion by 2030.

Global Human Growth Hormone Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Human Growth Hormone Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Human Growth Hormone Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Human Growth Hormone Market, highlighting leading vendors and their innovative profiles. These include Aeterna Zentaris, inc., Anhui Anke Biotechnology Co., Ltd, Biopartners GmbH, Eli Lilly and Company, Ferring B.V., GeneScience Pharmaceuticals Co., Ltd, Ipsen S.A, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Roche Holdings, Inc., Sandoz International GmbH, and Teva Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Human Growth Hormone Market to forecast the revenues and analyze trends in each of the following sub-markets:

Route of Administration
Intramuscular

Intravenous

Oral

Subcutaneous

Type
Amino Acid Derivatives

Peptide Hormones

Steroid Hormones

Distribution
Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Application
Growth Hormone Deficiency

Prader-Willi Syndrome

Turner Syndrome

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Human Growth Hormone Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Human Growth Hormone Market?
3. What are the technology trends and regulatory frameworks in the Human Growth Hormone Market?
4. What is the market share of the leading vendors in the Human Growth Hormone Market?
5. Which modes and strategic moves are suitable for entering the Human Growth Hormone Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Human Growth Hormone Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in the cases related to the hormonal disorders
5.1.1.2. Increase in the reimbursement policies
5.1.1.3. Growing growth hormone deficiency disorders
5.1.2. Restraints
5.1.2.1. Cost related to human growth hormone therapies procedures is high
5.1.3. Opportunities
5.1.3.1. Growing number of product launches of the human growth hormone
5.1.3.2. Surge in research and development fundings from the private as well as public sector
5.1.4. Challenges
5.1.4.1. Adverse impact of human growth hormone therapies on human bodies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Human Growth Hormone Market, by Route of Administration
6.1. Introduction
6.2. Intramuscular
6.3. Intravenous
6.4. Oral
6.5. Subcutaneous
7. Human Growth Hormone Market, by Type
7.1. Introduction
7.2. Amino Acid Derivatives
7.3. Peptide Hormones
7.4. Steroid Hormones
8. Human Growth Hormone Market, by Distribution
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy
9. Human Growth Hormone Market, by Application
9.1. Introduction
9.2. Growth Hormone Deficiency
9.3. Prader-Willi Syndrome
9.4. Turner Syndrome
10. Americas Human Growth Hormone Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Human Growth Hormone Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.
10. South Korea
11.
11. Taiwan
11.
12. Thailand
11.
13. Vietnam
12. Europe, Middle East & Africa Human Growth Hormone Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.
10. Nigeria
12.
11. Norway
12.
12. Poland
12.
13. Qatar
12.
14. Russia
12.
15. Saudi Arabia
12.
16. South Africa
12.
17. Spain
12.
18. Sweden
12.
19. Switzerland
12.
20. Turkey
12.
21. United Arab Emirates
12.
22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Aeterna Zentaris, inc.
14.1.2. Anhui Anke Biotechnology Co., Ltd
14.1.3. Biopartners GmbH
14.1.4. Eli Lilly and Company
14.1.5. Ferring B.V.
14.1.6. GeneScience Pharmaceuticals Co., Ltd
14.1.7. Ipsen S.A
14.1.8. Merck KGaA
14.1.9. Novartis AG
14.1.
10. Novo Nordisk A/S
14.1.
11. Pfizer Inc.
14.1.
12. Roche Holdings, Inc.
14.1.
13. Sandoz International GmbH
14.1.
14. Teva Pharmaceutical Industries Limited
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. HUMAN GROWTH HORMONE MARKET RESEARCH PROCESS
FIGURE 2. HUMAN GROWTH HORMONE MARKET SIZE, 2023 VS 2030
FIGURE 3. HUMAN GROWTH HORMONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HUMAN GROWTH HORMONE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HUMAN GROWTH HORMONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HUMAN GROWTH HORMONE MARKET DYNAMICS
FIGURE 7. HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 8. HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 12. HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. HUMAN GROWTH HORMONE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. HUMAN GROWTH HORMONE MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings